Literature DB >> 22507313

Why glucocorticosteroids should remain in the list of prohibited substances: a sports medicine viewpoint.

F Pigozzi, A Di Gianfrancesco, M Zorzoli, N Bachl, D Mc Donagh, J Cummiskey, L Di Luigi, Y Pitsiladis, P Borrione.   

Abstract

In addition to their therapeutic applications, glucocorticosteroids have been widely used and abused in the belief that these substances may enhance athletic performance. Analysis of athlete urine samples by antidoping laboratories around the world support this conclusion. It is commonly accepted in medical practice to use local glucocorticosteroid injections in the treatment of non-infectious local musculotendinous inflammatory conditions conveying symptom relief and often a speedier return to sporting activity. This practice is not to be considered illicit, but sports physicians must accept that such an intervention is not in itself an immediate cure and that an athlete will still require a period of recuperation before continuing sporting activity. How long such a period of recuperation should last is a matter of conjecture and there is little concrete data to support what is, or what is not, an acceptable period of inactivity. In the interest of athlete safety, we would propose to maintain systemic glucocorticosteroids on the World Anti-Doping Agency's (WADA) list of prohibited substances, both in and out-of-competition as well as a mandatory period of 48 hours of rest from play after receiving a local glucocorticosteroid injection.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22507313     DOI: 10.1177/039463201202500103

Source DB:  PubMed          Journal:  Int J Immunopathol Pharmacol        ISSN: 0394-6320            Impact factor:   3.219


  3 in total

Review 1.  The use of prohibited substances for therapeutic reasons in athletes affected by endocrine diseases and disorders: the therapeutic use exemption (TUE) in clinical endocrinology.

Authors:  L Di Luigi; F Pigozzi; P Sgrò; L Frati; A Di Gianfrancesco; M Cappa
Journal:  J Endocrinol Invest       Date:  2019-11-16       Impact factor: 4.256

2.  SporTRIA study-a multicentre trial protocol for excretion kinetics of triamcinolone acetonide following sport-related intra-articular injections in knees: definitions of the washout periods.

Authors:  Edem Allado; Mathias Poussel; Nicolas Gambier; Véronique Saunier; Marjorie Starck; Corinne Buisson; Gael Cinquetti; Eliane Albuisson; Bruno Chenuel
Journal:  BMJ Open       Date:  2021-06-09       Impact factor: 2.692

3.  Commentary.

Authors:  Konstantinos Natsis; Maria Piagkou
Journal:  J Neurosci Rural Pract       Date:  2013-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.